Naohiro Fujimoto

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 23

Top Topics

Combination Therapy

Metastatic Renal Cell Carcinoma

Radical Prostatectomy

Top Venues

International journal of urology : official journal of the Japanese Urological Association

Cancer management and research

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Takuto Hara, Yuto Matsushita, Ken-Ichi Harada, Naohiro Fujimoto, Masato Fujisawa, Hideaki Miyake
Clinical outcomes in patients with advanced urothelial carcinoma treated with enfortumab vedotin: A retrospective multicenter study in Japan. International journal of urology : official journal of the Japanese Urological Association (2024)
Shotaro Nakanishi, Yumi Fukushima, Junichi Inokuchi, Tomoaki Hakariya, Hiroaki Kakinoki, Hideki Enokida, Katsuaki Chikui, Hirofumi Matsuoka, Toshitaka Shin, Shoichiro Mukai, Tomomi Kamba, Masatoshi Eto, Ryoichi Imamura, Mitsuru Noguchi, Tsukasa Igawa, Nobuhiro Haga, Toshiyuki Kamoto, Naohiro Fujimoto, Seiichi Saito
Clinicopathological characteristics of adrenocortical carcinoma in the Kyushu-Okinawa area of Japan. International journal of urology : official journal of the Japanese Urological Association (2024)
Takuto Hara, Yuto Matsushita, Ken-Ichi Harada, Naohiro Fujimoto, Masato Fujisawa, Hideaki Miyake
Clinical outcomes in patients with advanced urothelial carcinoma treated with enfortumab vedotin: A retrospective multicenter study in Japan. International journal of urology : official journal of the Japanese Urological Association 31 (6) (2024)
Shotaro Nakanishi, Yumi Fukushima, Junichi Inokuchi, Tomoaki Hakariya, Hiroaki Kakinoki, Hideki Enokida, Katsuaki Chikui, Hirofumi Matsuoka, Toshitaka Shin, Shoichiro Mukai, Tomomi Kamba, Masatoshi Eto, Ryoichi Imamura, Mitsuru Noguchi, Tsukasa Igawa, Nobuhiro Haga, Toshiyuki Kamoto, Naohiro Fujimoto, Seiichi Saito
Clinicopathological characteristics of adrenocortical carcinoma in the Kyushu-Okinawa area of Japan. International journal of urology : official journal of the Japanese Urological Association 31 (5) (2024)
Shotaro Nakanishi, Yumi Fukushima, Junichi Inokuchi, Tomoaki Hakariya, Hiroaki Kakinoki, Hideki Enokida, Katsuaki Chikui, Hirofumi Matsuoka, Toshitaka Shin, Shoichiro Mukai, Tomomi Kamba, Masatoshi Eto, Ryoichi Imamura, Mitsuru Noguchi, Tsukasa Igawa, Nobuhiro Haga, Toshiyuki Kamoto, Naohiro Fujimoto, Seiichi Saito
Clinicopathological characteristics of adrenocortical carcinoma in the Kyushu-Okinawa area of Japan. International journal of urology : official journal of the Japanese Urological Association 31 (5) (2024)
Takuto Hara, Yuto Matsushita, Ken-Ichi Harada, Naohiro Fujimoto, Masato Fujisawa, Hideaki Miyake
Clinical outcomes in patients with advanced urothelial carcinoma treated with enfortumab vedotin: A retrospective multicenter study in Japan. International journal of urology : official journal of the Japanese Urological Association 31 (6) (2024)
Shotaro Nakanishi, Yumi Fukushima, Junichi Inokuchi, Tomoaki Hakariya, Hiroaki Kakinoki, Hideki Enokida, Katsuaki Chikui, Hirofumi Matsuoka, Toshitaka Shin, Shoichiro Mukai, Tomomi Kamba, Masatoshi Eto, Ryoichi Imamura, Mitsuru Noguchi, Tsukasa Igawa, Nobuhiro Haga, Toshiyuki Kamoto, Naohiro Fujimoto, Seiichi Saito
Clinicopathological characteristics of adrenocortical carcinoma in the Kyushu-Okinawa area of Japan. International journal of urology : official journal of the Japanese Urological Association 31 (5) (2024)
Shotaro Nakanishi, Yumi Fukushima, Junichi Inokuchi, Tomoaki Hakariya, Hiroaki Kakinoki, Hideki Enokida, Katsuaki Chikui, Hirofumi Matsuoka, Toshitaka Shin, Shoichiro Mukai, Tomomi Kamba, Masatoshi Eto, Ryoichi Imamura, Mitsuru Noguchi, Tsukasa Igawa, Nobuhiro Haga, Toshiyuki Kamoto, Naohiro Fujimoto, Seiichi Saito
Clinicopathological characteristics of adrenocortical carcinoma in the Kyushu-Okinawa area of Japan. International journal of urology : official journal of the Japanese Urological Association (2024)
Takuto Hara, Yuto Matsushita, Ken-Ichi Harada, Naohiro Fujimoto, Masato Fujisawa, Hideaki Miyake
Clinical outcomes in patients with advanced urothelial carcinoma treated with enfortumab vedotin: A retrospective multicenter study in Japan. International journal of urology : official journal of the Japanese Urological Association 31 (6) (2024)
Ikko Tomisaki, Mirii Harada, Shigeru Sakano, Michikazu Terado, Ryoichi Hamasuna, Shuji Harada, Hiroomi Matsumoto, Soichiro Akasaka, Yujiro Nagata, Akinori Minato, Ken-Ichi Harada, Naohiro Fujimoto
Differential impact of proton pump inhibitor on survival outcomes of patients with advanced urothelial carcinoma treated with chemotherapy versus pembrolizumab. International journal of urology : official journal of the Japanese Urological Association (2023)
Akira Yokomizo, Masaki Shiota, Futoshi Morokuma, Masatoshi Eto, Hideyasu Matsuyama, Hiroaki Matsumoto, Toshiyuki Kamoto, Naoki Terada, Kazuya Kawahara, Hideki Enokida, Shuichi Tatarano, Naohiro Fujimoto, Katsuyoshi Higasijima, Hideki Sakai, Tomoaki Hakariya, Tsukasa Igawa, Shigetaka Suekane, Tomomi Kamba, Yutaka Sugiyama, Junji Kishimoto, Seiji Naito
GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401. International journal of urology : official journal of the Japanese Urological Association 31 (4) (2023)
Ken-Ichi Harada, Hideaki Miyake, Junya Furukawa, Naohiro Fujimoto, Masato Fujisawa
Utility of prognostic prediction by early assessment of response to combined treatment with nivolumab plus ipilimumab in patients with treatment-naïve metastatic renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association (2023)
Akira Yokomizo, Masaki Shiota, Futoshi Morokuma, Masatoshi Eto, Hideyasu Matsuyama, Hiroaki Matsumoto, Toshiyuki Kamoto, Naoki Terada, Kazuya Kawahara, Hideki Enokida, Shuichi Tatarano, Naohiro Fujimoto, Katsuyoshi Higasijima, Hideki Sakai, Tomoaki Hakariya, Tsukasa Igawa, Shigetaka Suekane, Tomomi Kamba, Yutaka Sugiyama, Junji Kishimoto, Seiji Naito
GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401. International journal of urology : official journal of the Japanese Urological Association (2023)
Akira Yokomizo, Masaki Shiota, Futoshi Morokuma, Masatoshi Eto, Hideyasu Matsuyama, Hiroaki Matsumoto, Toshiyuki Kamoto, Naoki Terada, Kazuya Kawahara, Hideki Enokida, Shuichi Tatarano, Naohiro Fujimoto, Katsuyoshi Higasijima, Hideki Sakai, Tomoaki Hakariya, Tsukasa Igawa, Shigetaka Suekane, Tomomi Kamba, Yutaka Sugiyama, Junji Kishimoto, Seiji Naito
GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401. International journal of urology : official journal of the Japanese Urological Association 31 (4) (2023)
Ken-Ichi Harada, Ryo Sato, Yukari Bando, Asuka Sano, Yuto Matsushita, Keita Tamura, Tomoaki Terakawa, Junya Furukawa, Naohiro Fujimoto, Masato Fujisawa, Hideaki Miyake
Efficacy and safety of pembrolizumab and axitinib as first-line treatment for patients with advanced renal cell carcinoma: Real-world experience in Japan. International journal of urology : official journal of the Japanese Urological Association (2023)
Nobuki Furubayashi, Akinori Minato, Takahito Negishi, Naotaka Sakamoto, Yoohyun Song, Yoshifumi Hori, Toshihisa Tomoda, Mirii Harada, Shingo Tamura, Akihiro Miura, Hiroki Komori, Kentaro Kuroiwa, Narihito Seki, Naohiro Fujimoto, Motonobu Nakamura
Association Between Immune-Related Adverse Events and Efficacy and Changes in the Relative Eosinophil Count Among Patients with Advanced Urothelial Carcinoma Treated by Pembrolizumab. Cancer management and research 14 (2022)
Nobuki Furubayashi, Akinori Minato, Takahito Negishi, Naotaka Sakamoto, Yoohyun Song, Yoshifumi Hori, Toshihisa Tomoda, Mirii Harada, Shingo Tamura, Hiroki Kobayashi, Yamato Wada, Kentaro Kuroiwa, Narihito Seki, Naohiro Fujimoto, Motonobu Nakamura
The Eosinophil Changes, Efficacy and Safety of Pembrolizumab in Advanced Urothelial Carcinoma Patients with an Older Age and a Poor Performance Status. OncoTargets and therapy 15 (2022)
Ken-Ichi Harada, Hideaki Miyake, Junya Furukawa, Naohiro Fujimoto, Masato Fujisawa
Comprehensive assessments of immuno-oncology drug-based combination therapies as first-line treatment for advanced renal cell carcinoma. International journal of urology : official journal of the Japanese Urological Association 29 (8) (2022)
Kenichi Harada, Masaki Shiota, Akinori Minato, Masahiro Matsumoto, Ikko Tomisaki, Masato Fujisawa, Naohiro Fujimoto
Treatment Strategies for Metastatic Castration-Sensitive Prostate Cancer: From "All-Comers" to "Personalized" Approach. OncoTargets and therapy 14 (2021)
Kei Mizuno, Takayuki Sumiyoshi, Takatsugu Okegawa, Naoki Terada, Satoshi Ishitoya, Yu Miyazaki, Takahiro Kojima, Hiromichi Katayama, Naohiro Fujimoto, Shingo Hatakeyama, Masaki Shiota, Koji Yoshimura, Yoshiyuki Matsui, Shintaro Narita, Hiroaki Matsumoto, Ryoma Kurahashi, Hidenori Kanno, Katsuhiro Ito, Hiroko Kimura, Yuki Kamiyama, Takuro Sunada, Takayuki Goto, Takashi Kobayashi, Hitoshi Yamada, Norihiko Tsuchiya, Tomomi Kamba, Hideyasu Matsuyama, Tomonori Habuchi, Masatoshi Eto, Chikara Ohyama, Akihiro Ito, Hiroyuki Nishiyama, Hiroshi Okuno, Toshiyuki Kamoto, Akihiro Fujimoto, Osamu Ogawa, Shusuke Akamatsu
Clinical Impact of Detecting Low-Frequency Variants in Cell-Free DNA on Treatment of Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (22) (2021)
Nobuki Furubayashi, Akinori Minato, Takahito Negishi, Naotaka Sakamoto, Yoohyun Song, Yoshifumi Hori, Toshihisa Tomoda, Shingo Tamura, Kentaro Kuroiwa, Narihito Seki, Naohiro Fujimoto, Motonobu Nakamura
The Association of Clinical Outcomes with Posttreatment Changes in the Relative Eosinophil Counts and Neutrophil-to-Eosinophil Ratio in Patients with Advanced Urothelial Carcinoma Treated with Pembrolizumab. Cancer management and research 13 (2021)
Masaki Shiota, Naohiro Fujimoto, Yohei Sekino, Shigehiro Tsukahara, Shohei Nagakawa, Dai Takamatsu, Tatsuro Abe, Fumio Kinoshita, Shohei Ueda, Miho Ushijima, Takashi Matsumoto, Eiji Kashiwagi, Junichi Inokuchi, Takeshi Uchiumi, Yoshinao Oda, Masatoshi Eto
Clinical impact of HSD3B1 polymorphism by metastatic volume and somatic HSD3B1 alterations in advanced prostate cancer. Andrologia (2021)
Masaki Shiota, Naohiro Fujimoto, Eiji Kashiwagi, Masatoshi Eto
The Role of Nuclear Receptors in Prostate Cancer. Cells 8 (6) (2019)